ABBOTINDIA - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 2.8
| Stock Code | ABBOTINDIA | Market Cap | 57,929 Cr. | Current Price | 27,250 ₹ | High / Low | 37,000 ₹ |
| Stock P/E | 38.4 | Book Value | 1,888 ₹ | Dividend Yield | 1.74 % | ROCE | 46.2 % |
| ROE | 35.7 % | Face Value | 10.0 ₹ | DMA 50 | 28,207 ₹ | DMA 200 | 29,598 ₹ |
| Chg in FII Hold | 0.03 % | Chg in DII Hold | -0.11 % | PAT Qtr | 415 Cr. | PAT Prev Qtr | 366 Cr. |
| RSI | 41.6 | MACD | -348 | Volume | 8,058 | Avg Vol 1Wk | 10,071 |
| Low price | 25,999 ₹ | High price | 37,000 ₹ | PEG Ratio | 1.83 | Debt to equity | 0.05 |
| 52w Index | 11.4 % | Qtr Profit Var | 15.8 % | EPS | 710 ₹ | Industry PE | 29.1 |
📊 Analysis: ABBOTINDIA shows weak intraday potential. Current price (₹27,250) is below both 50 DMA (₹28,207) and 200 DMA (₹29,598), indicating bearish bias. RSI at 41.6 reflects weak momentum, while MACD (-348) is sharply negative, confirming downward pressure. Volume (8,058) is below weekly average (10,071), limiting intraday volatility. Despite strong fundamentals (ROCE 46.2%, ROE 35.7%), the stock is trading near the lower end of its 52-week range (11.4%), suggesting weak sentiment in the short term.
💰 Optimal Buy Price: ₹27,100–₹27,200 (near intraday support).
📈 Profit-Taking Exit Levels: ₹27,500–₹27,700 (short-term resistance zone).
📉 Stop-Loss / Loss Protection: ₹26,950 (below recent support).
⏱️ If Already Holding: Exit intraday if price fails to sustain above ₹27,300 with weakening RSI or declining volume. If momentum improves with stronger volume, hold until ₹27,700 resistance zone.
✅ Positive
- Strong ROCE (46.2%) and ROE (35.7%) indicate excellent efficiency.
- Low debt-to-equity (0.05) shows robust financial health.
- Quarterly PAT improved (₹415 Cr vs ₹366 Cr previous).
- Dividend yield of 1.74% provides income support.
⚠️ Limitation
- Trading below 50 DMA and 200 DMA, showing bearish trend.
- Negative MACD (-348) confirms weak momentum.
- Volume below weekly average, limiting intraday strength.
- Stock trading near lower end of 52-week range (11.4%).
📉 Company Negative News
- DII holding reduced (-0.11%), showing declining domestic institutional support.
📈 Company Positive News
- Quarterly profit growth (+15.8%) supports earnings momentum.
- FII holding increased slightly (+0.03%), showing marginal foreign interest.
- EPS at ₹710 reflects strong profitability.
🏭 Industry
- Industry PE is 29.1, lower than ABBOTINDIA’s 38.4, highlighting premium valuation.
- Pharmaceutical sector outlook remains stable with consistent demand.
🔎 Conclusion
ABBOTINDIA is a weak intraday candidate due to bearish technicals, low volume, and weak momentum indicators. Limited opportunities exist for cautious trades near ₹27,100–₹27,200 with exits around ₹27,700, but risk remains high. Best suited for defensive scalping rather than aggressive intraday positions.